Cargando…

The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity

BACKGROUND: The epidemiology of Crohn’s disease (CD) has changed over the past decades, demonstrating a trend toward increased prevalence in developing countries, while in developed countries, its incidence has stabilized. The study aimed to examine the profile of the key pro-inflammatory cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Qteishat, Ahmed, Kirov, Kiril, Bokov, Dmitry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677650/
https://www.ncbi.nlm.nih.gov/pubmed/36404304
http://dx.doi.org/10.1186/s12876-022-02562-w
_version_ 1784833850537410560
author Al Qteishat, Ahmed
Kirov, Kiril
Bokov, Dmitry
author_facet Al Qteishat, Ahmed
Kirov, Kiril
Bokov, Dmitry
author_sort Al Qteishat, Ahmed
collection PubMed
description BACKGROUND: The epidemiology of Crohn’s disease (CD) has changed over the past decades, demonstrating a trend toward increased prevalence in developing countries, while in developed countries, its incidence has stabilized. The study aimed to examine the profile of the key pro-inflammatory cytokines in the serum of patients with CD and establish their association with the severity and activity of the disease. METHODS: A total of 61 patients (29 women (47.5%), 32 men (52.5%) aged from 18 to 40 years (mean age (30.42 ± 2.51) years) with the verified diagnosis of CD in the active phase were examined. The control group consisted of 30 healthy people of corresponding age. RESULTS: CD is characterized by a reliable increase of pro-inflammatory cytokines in blood compared to healthy people: tumor necrosis factor-α (TNF-α) – by 4.45 times (137.46 ± 9.72 vs. 30.88 ± 2.08 pg/ml in healthy people, p < 0,001), interleukin-1α (IL-1α) – by 5.08 times (51.55 ± 4.36 vs. 10.14 ± 0.93 pg/ml, p < 0.001), interleukin-6 (IL-6) – by 2.16 times (20.03 ± 1.81 vs. 9.27 ± 0.52 pg/ml, p < 0.001), interleukin-8 (IL-8) – by 2.04 times (25.74 ± 2.05 vs. 12.62 ± 1.16 pg/ml, p < 0.001), and interferon-γ (IFN-γ) – by 5.30 times (208.63 ± 14.29 vs. 39.35 ± 2.40 pg/ml, p < 0.001). The authors have established direct correlations between the Crohn's disease activity index and blood content of TNF-α (r = 0.84, p < 0.013), INF-γ (r = 0.61, p < 0.028); between TNF-α and INF-γ content (r = 0.67, p < 0.023), IL-1α (r = 0.49, p < 0.042), IL-6 (r = 0.40, p < 0.045), and IL-8 (r = 0.51, p < 0.033); INF-γ and IL-1α (r = 0.53, p < 0.040), IL-6 (r = 0.37, p < 0.039), IL-8 (r = 0.44, p < 0.040). CONCLUSIONS: Patients with CD were found to have multiple cytokines (TNF-α, IL-1α, IL-6, IL-8, and IFN-γ,). The content of cytokines correlated positively with the CD activity index.
format Online
Article
Text
id pubmed-9677650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96776502022-11-22 The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity Al Qteishat, Ahmed Kirov, Kiril Bokov, Dmitry BMC Gastroenterol Research BACKGROUND: The epidemiology of Crohn’s disease (CD) has changed over the past decades, demonstrating a trend toward increased prevalence in developing countries, while in developed countries, its incidence has stabilized. The study aimed to examine the profile of the key pro-inflammatory cytokines in the serum of patients with CD and establish their association with the severity and activity of the disease. METHODS: A total of 61 patients (29 women (47.5%), 32 men (52.5%) aged from 18 to 40 years (mean age (30.42 ± 2.51) years) with the verified diagnosis of CD in the active phase were examined. The control group consisted of 30 healthy people of corresponding age. RESULTS: CD is characterized by a reliable increase of pro-inflammatory cytokines in blood compared to healthy people: tumor necrosis factor-α (TNF-α) – by 4.45 times (137.46 ± 9.72 vs. 30.88 ± 2.08 pg/ml in healthy people, p < 0,001), interleukin-1α (IL-1α) – by 5.08 times (51.55 ± 4.36 vs. 10.14 ± 0.93 pg/ml, p < 0.001), interleukin-6 (IL-6) – by 2.16 times (20.03 ± 1.81 vs. 9.27 ± 0.52 pg/ml, p < 0.001), interleukin-8 (IL-8) – by 2.04 times (25.74 ± 2.05 vs. 12.62 ± 1.16 pg/ml, p < 0.001), and interferon-γ (IFN-γ) – by 5.30 times (208.63 ± 14.29 vs. 39.35 ± 2.40 pg/ml, p < 0.001). The authors have established direct correlations between the Crohn's disease activity index and blood content of TNF-α (r = 0.84, p < 0.013), INF-γ (r = 0.61, p < 0.028); between TNF-α and INF-γ content (r = 0.67, p < 0.023), IL-1α (r = 0.49, p < 0.042), IL-6 (r = 0.40, p < 0.045), and IL-8 (r = 0.51, p < 0.033); INF-γ and IL-1α (r = 0.53, p < 0.040), IL-6 (r = 0.37, p < 0.039), IL-8 (r = 0.44, p < 0.040). CONCLUSIONS: Patients with CD were found to have multiple cytokines (TNF-α, IL-1α, IL-6, IL-8, and IFN-γ,). The content of cytokines correlated positively with the CD activity index. BioMed Central 2022-11-21 /pmc/articles/PMC9677650/ /pubmed/36404304 http://dx.doi.org/10.1186/s12876-022-02562-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Al Qteishat, Ahmed
Kirov, Kiril
Bokov, Dmitry
The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity
title The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity
title_full The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity
title_fullStr The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity
title_full_unstemmed The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity
title_short The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity
title_sort profile of the key pro-inflammatory cytokines in the serum of patients with cd and their association with the disease severity and activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677650/
https://www.ncbi.nlm.nih.gov/pubmed/36404304
http://dx.doi.org/10.1186/s12876-022-02562-w
work_keys_str_mv AT alqteishatahmed theprofileofthekeyproinflammatorycytokinesintheserumofpatientswithcdandtheirassociationwiththediseaseseverityandactivity
AT kirovkiril theprofileofthekeyproinflammatorycytokinesintheserumofpatientswithcdandtheirassociationwiththediseaseseverityandactivity
AT bokovdmitry theprofileofthekeyproinflammatorycytokinesintheserumofpatientswithcdandtheirassociationwiththediseaseseverityandactivity
AT alqteishatahmed profileofthekeyproinflammatorycytokinesintheserumofpatientswithcdandtheirassociationwiththediseaseseverityandactivity
AT kirovkiril profileofthekeyproinflammatorycytokinesintheserumofpatientswithcdandtheirassociationwiththediseaseseverityandactivity
AT bokovdmitry profileofthekeyproinflammatorycytokinesintheserumofpatientswithcdandtheirassociationwiththediseaseseverityandactivity